As the world becomes increasingly uncertain, STAAR Surgical Company (STAA) offers stability

STAAR Surgical Company (NASDAQ: STAA) closed the day trading at $72.60 up 2.79% from the previous closing price of $70.63. In other words, the price has increased by $+1.97 from its previous closing price. On the day, 596975 shares were traded. STAA stock price reached its highest trading level at $73.64 during the session, while it also had its lowest trading level at $70.60.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…



For a better understanding of STAA, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 16.31 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 153.82. For the most recent quarter (mrq), Quick Ratio is recorded 6.10 and its Current Ratio is at 6.60. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on December 28, 2022, Reiterated its Buy rating but revised its target price to $67 from $80 previously.

On December 08, 2022, Stifel started tracking the stock assigning a Hold rating and target price of $60.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 29 when BROADWOOD PARTNERS, L.P. bought 39,090 shares for $47.93 per share. The transaction valued at 1,873,431 led to the insider holds 8,783,082 shares of the business.

BROADWOOD PARTNERS, L.P. bought 100,000 shares of STAA for $4,697,610 on Dec 28. The 10% Owner now owns 8,743,992 shares after completing the transaction at $46.98 per share. On Dec 27, another insider, BROADWOOD PARTNERS, L.P., who serves as the 10% Owner of the company, bought 51,985 shares for $47.91 each. As a result, the insider paid 2,490,534 and bolstered with 8,643,992 shares of the company.

Valuation Measures:

As of this moment, STAAR’s Price-to-Earnings (P/E) ratio for their current fiscal year is 94.78, and their Forward P/E ratio for the next fiscal year is 72.17. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.16. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.34 while its Price-to-Book (P/B) ratio in mrq is 10.90.

Stock Price History:

Over the past 52 weeks, STAA has reached a high of $112.27, while it has fallen to a 52-week low of $46.35. The 50-Day Moving Average of the stock is 59.96, while the 200-Day Moving Average is calculated to be 70.59.

Shares Statistics:

Over the past 3-months, STAA traded about 773.43K shares per day on average, while over the past 10 days, STAA traded about 970.99k shares per day. A total of 48.10M shares are outstanding, with a floating share count of 47.89M. Shares short for STAA as of Oct 13, 2022 were 3.66M with a Short Ratio of 4.15M, compared to 3.03M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 7.62% and a Short% of Float of 15.89%.

Earnings Estimates

Current recommendations for the stock of the company come from 9 analysts. On average, analysts expect EPS of $0.13 for the current quarter, with a high estimate of $0.18 and a low estimate of $0.12, while EPS last year was $0.12. The consensus estimate for the next quarter is $0.12, with high estimates of $0.17 and low estimates of $0.1.

Analysts are recommending an EPS of between $0.81 and $0.68 for the fiscal current year, implying an average EPS of $0.71. EPS for the following year is $1.1, with 9 analysts recommending between $1.3 and $0.8.

Revenue Estimates

10 analysts predict $74.95M in revenue for the current quarter. It ranges from a high estimate of $77.1M to a low estimate of $74.4M. As of the current estimate, STAAR Surgical Company’s year-ago sales were $58.35M, an estimated increase of 28.40% from the year-ago figure. For the next quarter, 10 analysts are estimating revenue of $75.64M, an increase of 28.20% less than the figure of $28.40% in the same quarter last year. There is a high estimate of $76.84M for the next quarter, whereas the lowest estimate is $72M.

A total of 10 analysts have provided revenue estimates for STAA’s current fiscal year. The highest revenue estimate was $295.7M, while the lowest revenue estimate was $290.7M, resulting in an average revenue estimate of $294.94M. In the same quarter a year ago, actual revenue was $230.47M, up 28.00% from the average estimate. Based on 10 analysts’ estimates, the company’s revenue will be $374.87M in the next fiscal year. The high estimate is $393.58M and the low estimate is $361M. The average revenue growth estimate for next year is up 27.10% from the average revenue estimate for this year.